Exchange: OTC·Updated 02:13 PM EDT

ZLDAF Zelira Therapeutics Limited

$0.26
$0.00
(0.00%)
Today
Mkt Cap$3.42M
Vol45.00

About ZLDAF

Zelira Therapeutics Ltd. is a bio-pharmaceutical company, which engages in the research, development and commercialisation of cannabinoid-based formulations for the treatment of a variety of medical conditions. It operates through the following geographical segments: Australia and USA. The company was founded by Harry Karelis, Mara Gordon, Jason Peterson, and Stewart Washer on February 18, 2003 and is headquartered in Perth, Australia.
50

Neutral Sentiment

How do you feel about ZLDAF?

Advertisement|Remove ads.